Informed-money record
INKT · MiNK Therapeutics, Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
7
Named actors
2
Disclosed $ (bull / bear)
$0 / $12.6M
Recent disclosures
7 of 7 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-03-10 | Director Ryan Barbara | sold | $8K | SEC ↗ |
| 2026-03-10 | Director Ryan Barbara | sold | $8K | SEC ↗ |
| 2026-03-10 | Director Ryan Barbara | sold | $5K | SEC ↗ |
| 2026-03-09 | Director Ryan Barbara | sold | $2K | SEC ↗ |
| 2026-03-02 | Director Ryan Barbara | sold | $1K | SEC ↗ |
| 2026-02-27 | Director Ryan Barbara | sold | $4K | SEC ↗ |
| 2025-08-29 | Owner (via B. Riley Financial) Agenus Inc. | filed notice to sell | $12.6M | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals